IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis

References

• 2011. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC.
   Google Scholar
• Alam, R. 1997. Chemokines in allergic inflammation. J. Allergy Clin. Immunol. 99:273–277.
   PubMed Web of Science ®Google Scholar
• Baggiolini, M., Dewald, B., Moser, B. 1998. Chemokines and leukocyte traffic. Human chemokines: An update. Nature 392:565–568.
   PubMed Web of Science ®Google Scholar
• Beltrani, V. S. 2003. Occupational dermatoses. Curr. Opin. Allergy Clin. Immunol. 3:115–123.
   PubMedGoogle Scholar
• Chatterjee, A., Babu, R. J., Klausner, M., Singh, M. 2006. In vitro and in vivo comparison of dermal irritancy of jet fuel exposure using EpiDerm (EPI-200) cultured human skin and hairless rats. Toxicol. Lett. 167:85–94.
   PubMed Web of Science ®Google Scholar
• Corsini, E., Galli, C. L. 2000. Epidermal cytokines in experimental contact dermatitis. Toxicology 142:203–211.
   PubMed Web of Science ®Google Scholar
• Effendy, I., Loffler, H., Maibach, H. I. 2000. Epidermal cytokines in murine cutaneous irritant responses. J. Appl. Toxicol. 20:335–341.
   PubMedGoogle Scholar
• Fielding, C. A., McLoughlin, R. M., McLeod, L., Colmont, C. S., Najdovska, M., Grail, D., Ernst, M., Jones, S. A., Topley, N., Jenkins, B. J. 2008. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J. Immunol. 181:2189–2195.
   PubMed Web of Science ®Google Scholar
• Flier, J., Boorsma, D. M., Bruynzeel, D. P., van Beek, P. J., Stoof, T. J., Scheper, R. J., Willemze, R., Tensen, C. P. 1999. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J. Invest. Dermatol. 113:574–578.
   PubMed Web of Science ®Google Scholar
• Gallucci, R. M., Mickle, B. 2006. Inflammatory cytokine expression patterns in rat skin exposed to JP-8 jet fuel. Am. J. Pharm. Toxicol. 1:48–53.
   Google Scholar
• Gallucci, R. M., O’Dell, S. K., Rabe, D., Fechter, L. D. 2004. JP-8 jet fuel exposure induces inflammatory cytokines in rat skin. Int. Immunopharmacol. 4:1159–1169.
   PubMed Web of Science ®Google Scholar
• Gallucci, R. M., Simeonova, P. P., Matheson, J. M., Kommineni, C., Guriel, J. L., Sugawara, T., Luster, M. I. 2000. Impaired cutaneous wound healing in IL-6-deficient and immunosuppressed mice. FASEB J. 14:2525–2531.
   PubMed Web of Science ®Google Scholar
• Gallucci, R. M., Sugawara, T., Yucesoy, B., Berryann, K., Simeonova, P. P., Matheson, J. M., Luster, M. I. 2001. Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice. J. Interferon Cytokine Res. 21:603–609.
   PubMed Web of Science ®Google Scholar
• Hope, J. C., Campbell, F., Hopkins, S. J. 2000. Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response. Eur. J. Immunol. 30:197–203.
   PubMedGoogle Scholar
• Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topely, N., Jones, S. A. 2001. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14:705–714.
   PubMed Web of Science ®Google Scholar
• Kabbur, M. B., Rogers, J. V., Gunasekar, P. G., Garrett, C. M., Geiss, K. T., Brinkley, W. W., McDougal, J. N. 2001. Effect of JP-8 jet fuel on molecular and histological parameters related to acute skin irritation. Toxicol. Appl. Pharmacol. 175:83–88.
   PubMed Web of Science ®Google Scholar
• Koschier, F. J. 1999. Toxicity of middle distillates from dermal exposure. Drug Chem. Toxicol. 22:155–164.
   PubMed Web of Science ®Google Scholar
• Laskin, D. L. 2009. Macrophages and inflammatory mediators in chemical toxicity: A battle of forces. Chem. Res. Toxicol. 22:1376–1385.
   PubMed Web of Science ®Google Scholar
• Lin, Z. Q., Kondo, T., Ishida, Y., Takayasu, T., Mukaida, N. 2003. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J. Leukocyte Biol. 73:713–721.
   PubMed Web of Science ®Google Scholar
• Luckett-Chastain, L. R., Gallucci, R. M. 2009. Interleukin (IL)-6 modulates transforming growth factor-β expression in skin and dermal fibroblasts from IL-6-deficient mice. Br. J. Dermatol. 161:237–248.
   PubMedGoogle Scholar
• Mantovani, A., Schioppa, T., Porta, C., Allavena, P., Sica, A. 2006. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metast. Rev. 25:315–322.
   PubMed Web of Science ®Google Scholar
• Martin, P. 1997. Wound healing - aiming for perfect skin regeneration. Science 276:75–81.
   PubMed Web of Science ®Google Scholar
• Mathias, C. G. 1988. Occupational dermatoses. J. Am. Acad. Dermatol. 19:1107–1114.
   PubMedGoogle Scholar
• McDougal, J. N., Garrett, C. M. 2007. Gene expression and target tissue dose in the rat epidermis after brief JP-8 and JP-8 aromatic and aliphatic component exposures. Toxicol. Sci. 97:569–581.
   PubMed Web of Science ®Google Scholar
• McDougal, J. N., Robinson, P. J. 2002. Assessment of dermal absorption and penetration of components of a fuel mixture (JP-8). Sci. Total Environ. 288:23–30.
   PubMed Web of Science ®Google Scholar
• Meller, S., Laumerma, A. I., Kopp, F. M., Winterberg, F., Anthoni, M., Muller, A., Gombert, M., Haahtela, A., Alenius, H., Rieker, J., Dieu-Nosjean, M. C., Kubitza, R. C., Gleichmann, E., Ruzicka, T., Zlotnick, A., Homey, B. 2007. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: Memory T-cells make the difference. J. Allergy Clin. Immunol. 119:1470–1480.
   PubMedGoogle Scholar
• Monteiro-Riviere, N. A., Inman, A. O., Barlow, B. M., Baynes, R. E. 2006. Dermatotoxicity of cutting fluid mixtures: In vitro and in vivo studies. Cutan. Ocul. Toxicol. 25:235–247.
   PubMed Web of Science ®Google Scholar
• Moraes, T. J., Zurawska, J. H., Downey, G. P. 2006. Neutrophil granule contents in the pathogenesis of lung injury. Curr. Opin. Hematol. 13:21–27.
   PubMed Web of Science ®Google Scholar
• Morris, G. E., Maloof, C. C. 1952. Cutting-oil dermatitis. Ind. Med. Surg. 21:573–574.
   PubMedGoogle Scholar
• Patrick, E., Burkhalter, A., Maibach, H. I. 1987. Recent investigations of mechanisms of chemically induced skin irritation in laboratory mice. J. Invest. Dermatol. 88:24s–31s.
   PubMed Web of Science ®Google Scholar
• Ramos, G., Limon-Flores, A. Y., Ullrich, S. E. 2007. Dermal exposure to jet fuel suppresses delayed-type hypersensitivity: A critical role for aromatic hydrocarbons. Toxicol. Sci. 100:415–422.
   PubMed Web of Science ®Google Scholar
• Ramos, G., Nghiem, D. X., Walterscheid, J. P., Ullrich, S. E. 2002. Dermal application of jet fuel suppresses secondary immune reactions. Toxicol. Appl. Pharmacol. 180:136–144.
   PubMed Web of Science ®Google Scholar
• Sehgal, P. B. 1990. Interleukin-6: Molecular pathophysiology. J. Invest. Dermatol. 94:2S–6S.
   PubMed Web of Science ®Google Scholar
• Simeonova, P. P., Luster, M. I. 1995. Iron and reactive oxygen species in the asbestos-induced TNFα response from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12:676–783.
   PubMed Web of Science ®Google Scholar
• Sugawara, T., Gallucci, R. M., Simeonova, P. P., Luster, M. I. 2001. Regulation and role of IL-6 in wounded human epithelial keratinocytes. Cytokine 15:328–336.
   PubMedGoogle Scholar
• Turksen, K., Kupper, T., Degenstein, L., Williams, I., Fuchs, E. 1992. Interleukin-6: Insights to its function in skin by over-expression in transgenic mice. Proc. Natl. Acad. Sci. USA 89:5068–5072.
   PubMed Web of Science ®Google Scholar
• Ullrich, S. E., Lyons, H. J. 2000. Mechanisms involved in the immunotoxicity induced by dermal application of JP-8 jet fuel. Toxicol. Sci. 58:290–298.
   PubMed Web of Science ®Google Scholar
• Wang, X. P., Schunck, M., Kallen, K. J., Neumann, C., Trautwein, C., Rose-John, S., Proksch, E. 2004. The IL-6 cytokine system regulates epidermal permeability barrier homeostasis. J. Invest. Dermatol. 123:124–131.
   PubMed Web of Science ®Google Scholar
• Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., Achong, M. K. 1998. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:311–320.
   PubMed Web of Science ®Google Scholar